Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-21-067650

Director bought 10,000 shares at $1.39 ($13,900)

From the SEC's structured data for this filing

Trades in this filing

Haddadin Yezan Munther · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-12-02 Purchase : show line 1 in the form +10,000 $1.39 $13,900 30,000 D
Open-market purchases · 10,000 sh · avg $1.39 · $13,900
Loading xslF345X03/doc4.xml…